Price
$3
Increased by +4.17%
Dollar Volume
934.77 K
ADR%
4.95
Earnings Report Date (estimate)
Feb 1, 23 (-0.03)
Market Cap.
281.34 M
Shares Float
84.20 M
Shares Outstanding
93.78 M
Beta
1.50
Price / Earnings
-21.28
BPR
227.00
20D Range
2.06 3.07
50D Range
1.85 3.07
200D Range
1.70 3.58
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Feb 1, 23 -0.02
Decreased by -100.00%
-0.03
Increased by +33.33%
Nov 2, 22 -0.06
Decreased by -500.00%
-0.02
Decreased by -200.00%
Aug 10, 22 -0.04
Decreased by -180.00%
-0.06
Increased by +33.33%
Apr 27, 22 -0.01
Decreased by -326.86%
-0.04
Increased by +75.00%
Nov 3, 21 -0.01
Increased by 0.00%
-0.04
Increased by +75.00%
Aug 11, 21 -0.01
Decreased by -133.33%
-0.02
Increased by +50.00%
Jan 27, 21 0.05
Decreased by -58.33%
-0.02
Increased by +350.00%
Oct 29, 20 0.00
Increased by +104.01%
-0.07
Increased by +106.30%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 96.49 M
Decreased by -10.19%
-5.45 M
Decreased by -430.06%
Decreased by -5.65%
Decreased by -490.20%
Jun 30, 22 110.02 M
Decreased by -0.82%
-3.45 M
Increased by +68.88%
Decreased by -3.14%
Increased by +68.62%
Mar 31, 22 96.17 M
Decreased by -6.23%
-1.05 M
Decreased by -168.21%
Decreased by -1.09%
Decreased by -186.03%
Dec 31, 21 116.28 M
Increased by +19.31%
179.00 K
Decreased by -96.25%
Increased by +0.15%
Decreased by -96.85%
Sep 30, 21 107.44 M
Increased by +25.91%
-1.03 M
Decreased by -355.72%
Decreased by -0.96%
Decreased by -303.10%
Jun 30, 21 110.94 M
Increased by +16.80%
-11.09 M
Decreased by -7.20 K%
Decreased by -10.00%
Decreased by -6.15 K%
Mar 31, 21 102.56 M
Increased by +3.03%
-390.00 K
Decreased by -114.86%
Decreased by -0.38%
Decreased by -114.42%
Dec 31, 20 97.46 M
Decreased by -1.38%
4.77 M
Decreased by -55.47%
Increased by +4.89%
Decreased by -54.85%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.